• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AGEN:US

2.6500 USD 0.0100 0.38%

As of 14:42:38 ET on 04/24/2014.

Snapshot for Agenus Inc (AGEN)

Open: 2.6800 Day's Range: 2.5700 - 2.7399 Volume: 165,510
Previous Close: 2.6600 52wk Range: 2.2700 - 5.4000 1-Yr Rtn: -41.92%

Stock Chart for AGEN

No chart data available.
  • AGEN:US 2.6500
  • 1D
  • 1M
  • 1Y
2.6600
Interactive AGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AGEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0749
Est. EPS (USD) (12/2014) -0.6640
Est. PEG Ratio -
Market Cap (M USD) 167.18
Shares Outstanding (M) 62.17
30 Day Average Volume 876,417
Price/Book (mrq) -
Price/Sale (ttm) 24.5144
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AGEN

Agenus, Inc. develops vaccines. The Company researches vaccines for brain cancer, kidney cancer, herpes, lung cancer, melanoma, malaria, shingles, and Alzheimer's disease.

Garo H ArmenChairman/CEO/Co-FounderRobert B Stein "Bob"Chief Scientific Officer
Ozer BaysalChief Business OfficerKaren H ValentineVP/Chief Compliance Ofcr/Secy
More Company Profile & Key Executives for AGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil